achc stock — Acadia Healthcare Company Overview
Acadia Healthcare Company, Inc. (ACHC) — Stock overview
achc stock refers to the common shares of Acadia Healthcare Company, Inc., traded on the Nasdaq under the ticker ACHC. Acadia is a U.S.-based provider of behavioral healthcare services, operating inpatient psychiatric hospitals, specialty treatment centers, residential and outpatient programs. This article is a practical, source-driven guide for investors and researchers who want a comprehensive reference on achc stock, including company profile, financial measures, recent insider activity, regulatory matters, and where to follow authoritative filings.
Company profile
Acadia Healthcare Company, Inc. is a company focused on behavioral health services, headquartered in Franklin, Tennessee. Founded to acquire and develop behavioral healthcare facilities, Acadia operates a large network of inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics serving patients with psychiatric and substance use disorders. The company’s workforce spans clinical, administrative, and support personnel distributed across its facilities; Acadia describes its mission as providing evidence-based clinical care and improving access to behavioral health treatment.
Business lines and services
- Inpatient psychiatric hospitals: Acute-care psychiatric services for adults and adolescents requiring hospitalization.
- Specialty treatment facilities: Focused programs for conditions such as trauma-related disorders, co-occurring psychiatric and substance use disorders, and older-adult psychiatric care.
- Residential treatment centers: Longer-term, structured residential programs for adolescents and adults with severe behavioral health needs.
- Outpatient clinics and services: OP programs, intensive outpatient programs (IOP), partial hospitalization programs (PHP), and clinic-based psychiatric and therapy services.
- Ancillary and support services: Care coordination, telehealth where applicable, and clinical program development aligned with payer requirements.
Geographic footprint
Acadia’s primary operations are in the United States, with facilities distributed across multiple states and presence in Puerto Rico. The company has historically expanded through acquisitions and de novo development to broaden its geographic coverage. Any specific count of facilities and locations can change with acquisitions or dispositions; authoritative counts and facility lists are published in SEC filings and on the company’s investor relations materials.
Corporate history and milestones
Key corporate milestones for Acadia include its founding and subsequent expansion via acquisitions, entrance onto public markets, and strategic initiatives to diversify services and geographic reach. Notable event types to track in Acadia’s history are:
- Founding and early growth through facility acquisitions and partnerships.
- Major acquisition waves that expanded inpatient and residential capacity.
- Listing events and any change in exchange listing or ticker (ACHC on Nasdaq).
- Strategic initiatives focused on clinical program development, payer contracting, and integration of acquired assets.
For precise dates and transaction details, consult the company’s SEC filings (Form 10-K, Form 8-K) and investor relations releases.
Financial overview
This section summarizes public financial indicators reported by the company and reflected in market data providers. Financial figures can be found and verified in Acadia’s periodic SEC filings and public financial pages.
High-level metrics
Reported figures and sector comparisons (example figures reported in public summaries):
- Revenue growth: As of September 30, 2025, Acadia was reported to have a 4.41% revenue growth rate for the most recent three-month period cited in a public summary. (Source: company reports compiled in market coverage.)
- Gross margin: The company has been reported with a high gross margin figure (reported at ~96.43% in the referenced summary), indicating strong revenue retention before operating expenses, though margin measurement nuances exist across service lines.
- Earnings per share (EPS): A reported EPS figure of 0.4 in the referenced data indicates bottom-line pressures relative to some peers.
- Leverage / Debt-to-equity: A debt-to-equity ratio reported around 0.78 suggests moderate leverage compared with some industry peers.
- Valuation metrics: Example reported metrics include a price-to-earnings (P/E) ratio of ~12.38, a price-to-sales (P/S) ratio of ~0.4, and EV/EBITDA near 7.92, implying valuation measures below some industry averages in the referenced summary.
All numeric metrics above are from market summaries and should be cross-checked against the most recent SEC filings (10-Q, 10-K) and reputable financial-data providers for up-to-date verification.
Recent financial performance
Recent quarterly and year-to-date reports show trends in Acadia’s top-line and profitability. Public summaries indicate modest revenue growth in recent periods (e.g., a 4.41% increase in the referenced three-month period ending Sept 30, 2025). EPS and net income trends have varied by quarter due to acquisition-related costs, integration expenses, reimbursement dynamics, and other non-recurring items. For the latest quarter-by-quarter figures, refer to the company’s latest Form 10-Q or earnings release.
Balance sheet and cash flow highlights
Key balance-sheet points investors watch for achc stock include the company’s cash position, total debt levels, and free cash flow generation. The referenced summary notes a balanced debt approach with a debt-to-equity ratio around 0.78. Free cash flow trends may be impacted by capital expenditures for facility development and acquisition-related cash outflows. For granular figures (cash on hand, total liabilities, long-term debt maturities), consult the most recent audited 10-K and interim 10-Q filings.
Stock information
achc stock trades under the symbol ACHC on the Nasdaq exchange. Nasdaq trading hours and rules apply for intraday market activity. Typical public quote sources include Nasdaq’s own pages, major financial portals, and brokerage platforms. Official share counts, shares outstanding, and float are disclosed in periodic filings; these numbers can fluctuate with share issuances, buybacks, or secondary offerings.
Historical price performance
Historical price moves for achc stock have reflected a combination of sector dynamics, company-specific news (earnings, acquisitions, regulatory developments), and broader market trends. For example, in the period around January 21–22, 2026, public market coverage noted a trading price in the mid-teens per share (reported at approximately $14.53 at one point in the referenced coverage). Investors typically review multi-year charts, 52-week ranges, and total-return series to assess historical volatility and performance.
Dividends and shareholder returns
Acadia’s policies on dividends and capital returns are disclosed in corporate filings and investor communications. Historically, many behavioral health services companies prioritize reinvestment, debt management, and selective buybacks over high dividend payouts; achc stockholders should check the company’s investor relations statements for any declared dividends, share-repurchase programs, or other capital allocation plans. Public summaries in the provided sources do not indicate a regular high-yield dividend history for Acadia during the referenced period.
Ownership and major shareholders
Institutional ownership and insider stakes are disclosed in Form 13F filings and Form 4 submissions for insider transactions. Major institutional holders may include asset managers and mutual funds; insider holdings by executives and board members are reported in Form 4 filings and the company’s proxy statements. For the most current ownership data, review the latest proxy statement (DEF 14A) and 13F institutional filings.
Analyst coverage and market sentiment
acadia healthcare (achc stock) is covered by sell-side analysts who publish ratings, price targets, and research notes. Market consensus across brokers—buy, hold, sell distribution—and the range of price targets provides a snapshot of professional sentiment. Because coverage levels and recommendations change with earnings and news, consult up-to-date analyst summaries and broker reports through reputable financial-data vendors or the company’s investor relations disclosures.
Trading and technical information
Traders monitoring achc stock often look at liquidity (average daily volume), availability and open interest in options markets (where listed), short interest as a percent of float, and technical indicators such as moving averages and relative strength. These metrics are provided by market-data services and exchange statistics. High short interest or sudden option-volume spikes can accompany news-driven moves.
Legal, regulatory, and controversy matters
Behavioral healthcare providers operate in a regulated environment involving healthcare laws, payer reimbursement rules (Medicaid, Medicare, commercial), and clinical compliance requirements. Achc stock investors should track any investigations, regulatory actions, or litigation reported by the company or in the press. Public coverage sometimes highlights inquiries into billing practices, facility operations, or state-level regulatory issues. Such matters are disclosed in SEC filings (e.g., Form 8-K, risk-factor sections of the 10-K) and should be reviewed for detail and status.
Corporate governance and management
Key executives and board members are disclosed in the company’s proxy statements and investor materials. Executive changes (CEO, CFO) and insider transactions are reported on Forms 3, 4, and 5. Corporate governance items of interest include board composition, committee structure, and any recent management succession announcements. For recent insider moves, see the next section on insider activity.
Insider activity: January 21, 2026 filing
As of January 21, 2026, according to market coverage reported by Benzinga, Acadia Healthcare’s Chief Executive Officer, Osteen, reported acquiring stock options for 1,125,000 shares in a Form 4 filing with the U.S. Securities and Exchange Commission. The options grant price was reported at $11.68 per share and the filing was recorded on January 21. At a reported market price of approximately $14.53 per share during coverage the next morning, the notional value of those underlying shares (at that market price) was reported around $2,452,499 in the public summary of the coverage. Market summaries noted that insider purchases and option grants are disclosed under SEC rules and can be one data point market participants observe when assessing sentiment.
Important context about insider filings:
- Insiders (executive officers, directors, >10% owners) must file Form 4 within two business days of certain transactions under the Securities Exchange Act.
- Transaction codes in Form 4 indicate the nature of the transaction: P = open-market purchase, S = sale, C = conversion of option, A = grant/award/acquisition from the company, etc. Review the Form 4 for the exact code and additional details.
- Insider option grants may be structured with vesting schedules, performance conditions, or time-based vesting; the economic implication differs from a straight open-market purchase.
Source for the insider transaction summary: Benzinga coverage as reported around January 21–22, 2026 (market article summarizing an SEC Form 4 filing). For verification, consult the SEC’s EDGAR database and the company’s filings, which provide the Form 4 text and exact transaction codes and dates.
Risks
Principal investment risks for achc stock include the following, as disclosed in company filings and industry analysis. This is a factual summary of risk categories — not investment advice.
- Regulatory and reimbursement risk: Changes in Medicaid, Medicare, or private payer reimbursement policies can materially affect revenue for behavioral healthcare providers.
- Litigation and compliance risk: Healthcare providers can face investigations, contractual disputes, and regulatory enforcement actions; legal outcomes can involve fines, remediation costs, or reputational impacts.
- Operational / clinical risk: Maintaining quality of care, licensing, and staffing (including clinical workforce shortages) is critical; operational failures can lead to closures or sanctions.
- Payor mix and policy changes: Shifts in patient mix between commercial payers and public programs can affect reimbursement rates and margins.
- Market and financial risk: Debt-service obligations, capital requirements for facility expansion, and broader market volatility can influence company flexibility and stock reaction.
Recent news and developments
Investors commonly track the following types of news for achc stock:
- Earnings releases and conference-call transcripts that update revenue, margins, and guidance.
- SEC filings (10-Q, 10-K, 8-K) reporting material events such as acquisitions, senior management changes, or legal contingencies.
- Insider transactions (Form 4) such as the CEO’s reported option acquisition on January 21, 2026.
- State regulatory actions, facility licensing updates, or investigation notices affecting operations.
- Strategic partnerships, facility openings or divestitures, and capital-markets activities.
Each item should be cross-referenced to the primary source (press release, SEC filing, or verified news outlet) for accuracy and timing.
Comparable companies and industry context
Acadia operates in the behavioral healthcare segment of the broader health services industry. Comparable companies for context often include national and regional providers of behavioral health services, specialty psychiatric hospital operators, and companies focused on substance use and residential treatment. Peer comparisons typically use revenue growth, margins, leverage, and valuation multiples (P/E, EV/EBITDA, P/S) to provide relative perspective.
How to research and follow ACHC
Authoritative sources to track achc stock and company disclosure include:
- SEC filings (Form 10-K annually, Form 10-Q quarterly, Form 8-K for material events, and Form 4 for insider transactions) available on the SEC’s EDGAR system.
- Acadia Healthcare’s investor relations site for press releases, earnings materials, and presentations.
- Major financial-data portals and market pages for live quotes, historical data, and analyst summaries.
- Broker research and sell-side analyst reports for coverage and consensus estimates.
- Regulatory and state health department notices for facility-level matters.
For trading execution and market access, Bitget provides a platform for U.S.-listed equities and research tools for investors who already use the Bitget ecosystem. For Web3 wallet needs when engaging with digital asset services, consider Bitget Wallet where applicable. (Note: achc stock is an equity security — regulatory and custody rules differ from digital assets.)
See also
- Behavioral healthcare industry overview
- Health services stocks and valuation metrics
- Nasdaq-listed healthcare companies
References
The factual assertions in this article are based on public company disclosures and market coverage. Key reference categories include:
- SEC filings (10-K, 10-Q, 8-K, Form 4) for Acadia Healthcare Company, Inc.
- Acadia Healthcare investor relations materials and press releases.
- Market-data summaries and coverage (example reporting by Benzinga summarizing the January 21, 2026 Form 4 filing).
- Financial-data providers and market pages for valuation and ratio snapshots.
As of January 21, 2026, according to Benzinga’s market coverage, the CEO filed a Form 4 showing acquisition of options for 1,125,000 shares at $11.68 per share; Benzinga’s automated coverage noted trading near $14.53 the following morning in published summaries. For verification, consult the SEC Form 4 and the company’s filings. (Source example: Benzinga market article, Jan 21–22, 2026.)
External links
Suggested items to consult (searchable by name in your browser or via official portals): Acadia Healthcare investor relations, SEC EDGAR filings for Acadia Healthcare Company, and major market quote pages for ACHC. When trading or following markets, consider using Bitget for execution and Bitget Wallet for digital-asset custody where applicable.
Note: This article provides an informational company and stock overview. It is neutral and factual; it is not investment advice, a recommendation, or an endorsement of any security. For investment decisions consult licensed financial professionals and the company’s official filings.





















